These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35083957)

  • 1. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.
    Fitzpatrick CM; Anderson BT; Agin-Liebes G; Guydish J
    J Psychoactive Drugs; 2022; 54(4):324-327. PubMed ID: 35083957
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.
    Lugo-Radillo A; Cortes-Lopez JL
    J Psychoactive Drugs; 2021; 53(2):146-148. PubMed ID: 33225874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psilocybin for the Treatment of Obsessive-Compulsive Disorders.
    Ehrmann K; Allen JJB; Moreno FA
    Curr Top Behav Neurosci; 2022; 56():247-259. PubMed ID: 34784024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Automutilation after consumption of hallucinogenic mushrooms].
    Attema-de Jonge ME; Portier CB; Franssen EJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
    Moreno FA; Wiegand CB; Taitano EK; Delgado PL
    J Clin Psychiatry; 2006 Nov; 67(11):1735-40. PubMed ID: 17196053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psilocybin and Obsessive Compulsive Disorder.
    Wilcox JA
    J Psychoactive Drugs; 2014; 46(5):393-5. PubMed ID: 25364991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hallucinogenic mushrooms].
    Reingardiene D; Vilcinskaite J; Lazauskas R
    Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
    Sousa TR; Rema J; Machado S; Novais F
    Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.
    Modlin NL; Miller TM; Rucker JJ; Kirlic N; Lennard-Jones M; Schlosser D; Aaronson ST
    J Affect Disord; 2023 Apr; 326():18-25. PubMed ID: 36707036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallucinogens and obsessive-compulsive disorder.
    Perrine DM
    Am J Psychiatry; 1999 Jul; 156(7):1123. PubMed ID: 10401480
    [No Abstract]   [Full Text] [Related]  

  • 14. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
    Jastrzebski M; Bala A
    Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.
    Suleiman M; Basu A; Belal S; Jacob T
    J Nerv Ment Dis; 2022 Aug; 210(8):638-639. PubMed ID: 35900779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
    Musshoff F; Madea B; Beike J
    Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.
    Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC
    Drug Alcohol Depend; 2013 Jun; 130(1-3):245-8. PubMed ID: 23265089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magic mushroom compound is a potential treatment for patients with major depression.
    Nurs Stand; 2016 Jun; 30(41):15. PubMed ID: 27286599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psilocybin Conspectus: Status, Production Methods, and Considerations.
    Plotnik L; Gibbs G; Graham T
    Int J Med Mushrooms; 2022; 24(1):1-11. PubMed ID: 35442591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.